featured
Outcomes of Switch From Off-Label Swallowed Topical Corticosteroids to Budesonide Orodispersible Tablets in Patients With Eosinophilic Esophagitis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Clinical Gastroenterology and Hepatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Switch from Off-Label Swallowed Topical Corticosteroids to Budesonide Orodispersible Tablets in Eosinophilic Esophagitis patients
Clin. Gastroenterol. Hepatol. 2024 Nov 12;[EPub Ahead of Print], G Pellegatta, FP Giugliano, E Mastrorocco, B Ilaria, C Hassan, A RepiciFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.